| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |